Pharmacogenetics is primarily concerned with human DNA variation but there have also been important recent advances in understanding variation in tumor DNA, especially in the design of drugs that target mutated genes within tumors. The current article will focus only on recent developments and current challenges in pharmacogenetics in germline DNA. Targeted therapies where the response depends on tumor genotype are outside the scope of this article but have been reviewed recently elsewhere.
Current pharmacogenetics knowledge can be considered on an individual gene, therapeutic area or individual drug basis. This article will provide a general background on gene families of particular relevance to pharmacogenetics but the emphasis will be on individual drugs.
Case Report: Journal of Genetic Disorders
Case Report: Journal of Genetic Disorders
Review Article: Journal of Genetic Disorders
Review Article: Journal of Genetic Disorders
Commentary: Journal of Genetic Disorders
Commentary: Journal of Genetic Disorders
Editorial: Journal of Genetic Disorders
Editorial: Journal of Genetic Disorders
Case Report: Journal of Genetic Disorders
Case Report: Journal of Genetic Disorders
ScientificTracks Abstracts: Journal of Stem Cell Biology and Transplantation
ScientificTracks Abstracts: Journal of Stem Cell Biology and Transplantation
Journal of Genetic Disorders received 28 citations as per Google Scholar report